MYOPEPDYS (VESLETEPLIRSEN) INJECTION
Dead / Abandoned — Abandoned — no statement of use filed (as of 30 Jun 2025)
What this means for you
This application is over — abandoned 30 Jun 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 98370905
- Mark type
- Design + words
- Filed
- 23 Jan 2024
- Published for opposition
- 01 Oct 2024
- Abandoned
- 30 Jun 2025
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations based on morpholino oligomer technology platform for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Pharmaceutical preparations that modulate RNA expression for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Gene therapy products, namely, gene delivery pharmaceuticals; Pharmaceutical preparations for gene therapy, gene editing, and genome editing; Gene therapy products in the nature of pharmaceuticals for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Biological preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Viruses, viral vectors and viral constructs for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations, biological preparations and gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of genetic disorders and diseases
- Class 041 — Education and entertainment services: Medical training and teaching
- Class 044 — Medical, beauty and agricultural services: Medical services; providing health information
Owner
- Sarepta Therapeutics, Inc., Cambridge, MA, US
- Sarepta Therapeutics, Inc., Cambridge, MA, US
Prosecution history
- 30 Jun 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 30 Jun 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 26 Nov 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 01 Oct 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 01 Oct 2024 — PUBLISHED FOR OPPOSITION
- 11 Sept 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 23 Aug 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 23 Aug 2024 — EXAMINER'S AMENDMENT ENTERED
- 23 Aug 2024 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 23 Aug 2024 — EXAMINERS AMENDMENT E-MAILED
- 23 Aug 2024 — EXAMINERS AMENDMENT -WRITTEN
- 19 Aug 2024 — ASSIGNED TO EXAMINER
- 28 May 2024 — NOTICE OF DESIGN SEARCH CODE E-MAILED
- 28 May 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 23 Jan 2024 — NEW APPLICATION ENTERED